Exosome-mediated intercellular communication and PROTACs delivery: A Dual Approach for Precision Therapy in Colon Cancer DOI
Popat Mohite, Abhijeet Puri, Shubham Munde

и другие.

Journal of Drug Delivery Science and Technology, Год журнала: 2024, Номер unknown, С. 106596 - 106596

Опубликована: Дек. 1, 2024

Язык: Английский

Engineered brain‐targeting exosome for reprogramming immunosuppressive microenvironment of glioblastoma DOI Creative Commons
Jun Yang, Yong Li,

Shaoping Jiang

и другие.

Exploration, Год журнала: 2024, Номер unknown

Опубликована: Июнь 26, 2024

Abstract The immunosuppressive microenvironment of glioblastoma multiforme (GBM) severely impacts the response to various treatments, including systemic chemotherapy. Targeted reprogramming GBM using RNA interference (RNAi) is largely restricted by poor brain delivery efficiency and targeting specificity. Herein, an acid‐cleavable transferrin (Tf) decorated engineering exosome‐based brain‐targeting system (ACTE) was proposed efficiently deliver small towards transform growth factor‐β (siTGF‐β) doxorubicin (DOX) site for combination chemo‐immunotherapy. siTGF‐β DOX co‐loaded ACTE, termed as DOX&siTGF‐β@ACTE (Ds@ACTE), designed specifically recognize Tf receptor (TfR) on blood‐brain barrier (BBB). Subsequently, Ds@ACTE undergoes acid‐responsive detachment within lysosome capillary endothelial cells, leading separation DOX&siTGF‐β@Exo (Ds@Exo) from Tf‐TfR complex enhanced BBB transcytosis. After crossing BBB, separated Ds@Exo can further target cells via homing effect. In vivo studies validated that significantly downregulated TGF‐β expression reprogram microenvironment, thereby reinforce chemotherapeutic effect DOX‐induced anti‐tumor immune response. effectiveness this strategy not only provide thinking designing a more intelligent based engineered exosomes but also explore effective treatment regimen GBM.

Язык: Английский

Процитировано

20

Mesenchymal Stem Cell-Derived Exosomes as Drug Delivery Vehicles in Disease Therapy DOI Open Access

Wenzhe Zhao,

Kaixuan Li,

Liangbo Li

и другие.

International Journal of Molecular Sciences, Год журнала: 2024, Номер 25(14), С. 7715 - 7715

Опубликована: Июль 14, 2024

Exosomes are small vesicles containing proteins, nucleic acids, and biological lipids, which responsible for intercellular communication. Studies have shown that exosomes can be utilized as effective drug delivery vehicles to accurately deliver therapeutic substances target tissues, enhancing effects reducing side effects. Mesenchymal stem cells (MSCs) a class of widely used tissue engineering, regenerative medicine, immunotherapy. derived from MSCs special immunomodulatory functions, low immunogenicity, the ability penetrate tumor high yield, expected engineered into efficient systems. Despite promising promise MSC-derived exosomes, exploring their optimal preparation methods, drug-loading modalities, potential remains challenging. Therefore, this article reviews related characteristics, application, risks systems in order find breakthroughs.

Язык: Английский

Процитировано

15

Hydrogels loaded with MSC‐derived small extracellular vesicles: A novel cell‐free tissue engineering system for diabetic wound management DOI Creative Commons
Weicheng Zhong,

Hao Meng,

Liqian Ma

и другие.

View, Год журнала: 2024, Номер 5(4)

Опубликована: Июль 18, 2024

Abstract With the aging and obesity era, increasing incidence of diabetes diabetic complications, especially non‐healing wounds, imposes a serious economic burden on both patients society. The complex microenvironments, including hyperglycemia, bacterial infection, ischemia, nerve damage, lead to prolonged inflammation proliferation phase wounds. Mesenchymal stem cell‐derived small extracellular vesicles (MSC‐sEVs), which contain rich variety therapeutic molecules, have been chased for decades because their potential roles in cellular communication, tissue regeneration, drug delivery. As powerful tools controlled‐sustained release sEVs, biocompatible hydrogels applied wide range biomedical applications. Herein, we first summarize pathological features such as angiopathy, neuropathy, immune cell dysfunction. Then, discuss biological properties, performance, stability pure MSC‐sEVs. After that, components, application patterns, responsiveness hydrogels. Next, loading avenues MSC‐sEVs into hydrogel, behaviors sEVs from hydrogels, influence crosslinking method hydrogel‐sEV composites. Finally, provide an overview current applications loaded with novel cell‐free engineering system managing wounds propose critical unsolved issues. This review is expected meaningful guidance developing wound management.

Язык: Английский

Процитировано

10

Exosomes as targeted diagnostic biomarkers: Recent studies and trends DOI

Aida Abbasi Marjani,

Nader D. Nader, Ayuob Aghanejad

и другие.

Life Sciences, Год журнала: 2024, Номер 354, С. 122985 - 122985

Опубликована: Авг. 14, 2024

Язык: Английский

Процитировано

7

Tumor-Repopulating Cell-Derived Microparticle-Based Therapeutics Amplify the Antitumor Effect through Synergistic Inhibition of Chemoresistance and Immune Evasion DOI

Nana Bie,

Shiyu Li, Qingle Liang

и другие.

Molecular Pharmaceutics, Год журнала: 2025, Номер unknown

Опубликована: Янв. 8, 2025

Traditional chemotherapy often encounters failure attributed to drug resistance mediated by tumor-repopulating cells (TRCs) and chemotherapy-triggered immune suppression. The effective inhibition of TRCs the mitigation drug-induced suppression are pivotal for successful chemotherapy. Here, TRC-derived microparticles (3D-MPs), characterized excellent tumor-targeting high TRC uptake properties, utilized deliver metformin chemotherapeutic doxorubicin ((DOX+Met)@3D-MPs). (DOX+Met)@3D-MPs efficiently enhance tumor accumulation highly internalized in TRCs. Additionally, significantly decrease upregulation P-glycoprotein expression intracellular retention, resulting increased sensitivity immunogenic cell death improved antitumor immunity. Importantly, also remarkably reduce chemotherapy-induced PD-L1 expression, alleviating facilitated PD-L1/PD-1 axis further immunological response against malignancy. These results underscore (DOX+Met)@3D-MPs' potential as a viable platform augmenting efficacy therapies.

Язык: Английский

Процитировано

0

Barcoded Hybrids of Extracellular Vesicles and Lipid Nanoparticles for Multiplexed Analysis of Tissue Distribution DOI Creative Commons
Alena Ivanova, Renata Chalupska, Ana F. Louro

и другие.

Advanced Science, Год журнала: 2025, Номер unknown

Опубликована: Янв. 16, 2025

Abstract Targeted delivery of therapeutic agents is a persistent challenge in modern medicine. Recent efforts this area have highlighted the utility extracellular vesicles (EVs) as drug carriers, given that they naturally occur bloodstream and tissues, can be loaded with wide range molecules. However, biodistribution tissue tropism EVs remain difficult to study systematically. Here, multiplexed approach developed for simultaneous tracking from various cell lines within single vivo experiment. are used 16 different lines, through controlled fusion lipid nanoparticles (LNPs) carrying single‐stranded DNA barcodes, uniquely barcoded hybrid EV particle (hEV) library generated. These hEVs combined profiling mice, discovered HAP1‐derived demonstrated lung tropism, suggesting these may targeted into tissue. To examine possibility further, it shown HAP1 hEV Cre mRNA displayed functional lungs. Overall, technology enables rapid across sources, which poised improve throughput extent studies, while reducing number animals required research.

Язык: Английский

Процитировано

0

Tolerogenic nanovaccines for the treatment of type I allergic diseases DOI
Yueping Ren,

Daoke Yao,

Fang Wu

и другие.

Journal of Controlled Release, Год журнала: 2025, Номер 380, С. 664 - 685

Опубликована: Фев. 17, 2025

Язык: Английский

Процитировано

0

Healing Wounds in Diabetes: Exploring Cutting-Edge Natural Extracellular Vesicle Therapeutics DOI

Mumtaj Bano Miya,

Pankaj Chaturvedi,

Vandana Pathak

и другие.

Obesity Medicine, Год журнала: 2025, Номер unknown, С. 100597 - 100597

Опубликована: Фев. 1, 2025

Язык: Английский

Процитировано

0

Research progress in the extraction, purification, structural features, biological activities, and structure-activity relationships from Prunella vulgaris polysaccharides DOI

Xiaopeng Ai,

Peiling Yu,

Yaqin Hou

и другие.

International Journal of Biological Macromolecules, Год журнала: 2025, Номер 307, С. 141957 - 141957

Опубликована: Март 10, 2025

Язык: Английский

Процитировано

0

Engineered Exosome‐Based Senolytic Therapy Alleviates Stroke by Targeting p21+CD86+ Microglia DOI Creative Commons
Jialei Yang, Shipo Wu, Miao He

и другие.

Exploration, Год журнала: 2025, Номер unknown

Опубликована: Март 6, 2025

ABSTRACT Stroke remains the leading cause of neurological mortality and disability worldwide, with post‐stroke inflammation significantly hindering neural repair. Despite its critical impact, mechanism‐based therapeutic strategies are scarce. In this study, we uncovered a critically important yet previously unexamined cell population, p21 + CD86 microglia, which accumulated in ischemic region. Unexpectedly, discovered that interacted C/EBPβ, driving C/EBPβ‐dependent transcription upregulating key pro‐inflammatory factors such as Il6 , Il1β Cxcl2 Cxcl10 . To specifically target eliminate these pathogenic engineered exosomes peptide selectively binds microglia loaded them senolytic Quercetin. Furthermore, developed an optimized, stable Que@micro‐Exo formulation. Systemic administration robustly reduced suppressed their phenotype. Notably, functional analyses revealed treatment mitigated blood‐brain barrier disruption, promoted beneficial microglial polarization, decreased neutrophil infiltration, enhanced recovery following cerebral ischemia, all favorable safety profile. Our preclinical findings lay foundation for targeting novel strategy, highlighting potential exosome‐based anti‐inflammatory therapy stroke other central nervous system disorders.

Язык: Английский

Процитировано

0